These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
789 related articles for article (PubMed ID: 16079253)
21. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Stimson RH; Walker BR Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154 [TBL] [Abstract][Full Text] [Related]
22. Cortisone induces insulin resistance in C2C12 myotubes through activation of 11beta-hydroxysteroid dehydrogenase 1 and autocrinal regulation. Park SY; Bae JH; Cho YS Cell Biochem Funct; 2014 Apr; 32(3):249-57. PubMed ID: 24122936 [TBL] [Abstract][Full Text] [Related]
23. Expression and putative role of 11 beta-hydroxysteroid dehydrogenase isozymes within the human eye. Rauz S; Walker EA; Shackleton CH; Hewison M; Murray PI; Stewart PM Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2037-42. PubMed ID: 11481269 [TBL] [Abstract][Full Text] [Related]
24. Evolution of 11beta-hydroxysteroid dehydrogenase-type 1 and 11beta-hydroxysteroid dehydrogenase-type 3. Baker ME FEBS Lett; 2010 Jun; 584(11):2279-84. PubMed ID: 20350543 [TBL] [Abstract][Full Text] [Related]
25. Effect of immunosuppressive and other drugs on the cortisol-cortisone shuttle in human kidney and liver. Quinkler M; Jussli J; Bähr V; Pfeiffer AF; Lepenies J; Diederich S Horm Metab Res; 2007 Aug; 39(8):555-9. PubMed ID: 17712719 [TBL] [Abstract][Full Text] [Related]
26. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity. Müssig K; Remer T; Haupt A; Gallwitz B; Fritsche A; Häring HU; Maser-Gluth C Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276 [TBL] [Abstract][Full Text] [Related]
27. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. Cooper MS; Bujalska I; Rabbitt E; Walker EA; Bland R; Sheppard MC; Hewison M; Stewart PM J Bone Miner Res; 2001 Jun; 16(6):1037-44. PubMed ID: 11393780 [TBL] [Abstract][Full Text] [Related]
28. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance. Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237 [TBL] [Abstract][Full Text] [Related]
29. Cortisol, 11beta-hydroxysteroid dehydrogenases, and hypertension. van Uum SH; Lenders JW; Hermus AR Semin Vasc Med; 2004 May; 4(2):121-8. PubMed ID: 15478032 [TBL] [Abstract][Full Text] [Related]
30. Impaired protein stability of 11beta-hydroxysteroid dehydrogenase type 2: a novel mechanism of apparent mineralocorticoid excess. Atanasov AG; Ignatova ID; Nashev LG; Dick B; Ferrari P; Frey FJ; Odermatt A J Am Soc Nephrol; 2007 Apr; 18(4):1262-70. PubMed ID: 17314322 [TBL] [Abstract][Full Text] [Related]
31. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus. Pereira CD; Azevedo I; Monteiro R; Martins MJ Diabetes Obes Metab; 2012 Oct; 14(10):869-81. PubMed ID: 22321826 [TBL] [Abstract][Full Text] [Related]
32. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes. Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316 [TBL] [Abstract][Full Text] [Related]
33. Human renal 11beta-hydroxysteroid dehydrogenase 1 functions and co-localizes with COX-2. Gong R; Morris DJ; Brem AS Life Sci; 2008 Mar; 82(11-12):631-7. PubMed ID: 18261751 [TBL] [Abstract][Full Text] [Related]
34. Diet and the role of 11beta-hydroxysteroid dehydrogenase-1 on obesity. London E; Castonguay TW J Nutr Biochem; 2009 Jul; 20(7):485-93. PubMed ID: 19443197 [TBL] [Abstract][Full Text] [Related]